Management and Treatment of Non-Convulsive Seizures
For patients suspected of having non-convulsive seizures, promptly perform EEG within 24 hours and treat identified seizures with standard antiseizure medications (levetiracetam, valproate, or phenytoin/fosphenytoin), as treatment of nonconvulsive seizures is reasonable and may prevent secondary brain injury. 1
Immediate Diagnostic Approach
EEG Acquisition and Timing
- Order EEG immediately for any patient who does not follow commands after a seizure or has unexplained altered mental status, as this is a Class 1 recommendation with the highest level of evidence 1
- Perform EEG within 24 hours of presentation, as early EEG (within 16 hours) detects epileptiform discharges in 52.1% of cases versus only 20.2% after 16 hours 2
- Expect an average response time of approximately 3 hours from EEG request to preliminary reading, so order early 1, 3
- Use continuous EEG monitoring rather than brief 20-30 minute recordings when feasible, as routine EEG misses approximately 50% of nonconvulsive seizures compared to prolonged monitoring 2, 4
Patient Populations Requiring Urgent EEG
- Post-cardiac arrest patients who remain comatose after return of spontaneous circulation 1
- Patients with persistent altered consciousness 60 minutes after apparent seizure termination 2, 3
- Comatose ICU patients with unexplained impairment of mental status 1, 2
- Any patient with altered mental status and history of seizures, witnessed seizure activity, or abnormal eye movements 5, 6
EEG Interpretation Framework
Diagnostic Criteria for Nonconvulsive Seizures
Use American Clinical Neurophysiology Society criteria to classify findings 1:
Electrographic Seizure:
- Epileptiform discharges averaging >2.5 Hz for ≥10 seconds, OR
- Any pattern with definite evolution (≥2 sequential changes in frequency, morphology, or location) lasting ≥10 seconds 1
Electrographic Status Epilepticus:
- Any pattern qualifying as electrographic seizure for ≥10 continuous minutes, OR
- Total duration ≥20% of any 60-minute monitoring period 1
Ictal-Interictal Continuum (possible status epilepticus):
- Periodic discharges or spike/sharp-wave patterns averaging >1.0 and ≤2.5 Hz over 10 seconds, OR
- Patterns averaging ≥0.5 Hz and ≤1.0 Hz with additional features (superimposed fast activity, rhythmic activity, or sharp waves) 1
Monitoring Duration
- Continue EEG for at least 24 hours if the patient does not return to baseline neurologic function 1
- Approximately 25% of patients have ongoing electrical seizures despite cessation of visible convulsive activity 7, 3
- In post-cardiac arrest patients, 10-35% who do not follow commands have seizures detectable only by EEG 1
Treatment Algorithm
First-Line Treatment for Identified Nonconvulsive Seizures
Treat nonconvulsive seizures detected by EEG with standard antiseizure medications (Class 2a recommendation) 1:
Preferred Initial Agents (choose one based on clinical context):
- Loading dose: 20-60 mg/kg/day (typically 1000-3000 mg IV)
- Advantages: Fewer drug interactions, no cardiac effects, rapid administration
- Most commonly used in survey of neurologists managing nonconvulsive seizures 5
- Loading dose: 15-20 mg/kg IV (can be given rapidly)
- Advantages: Broad-spectrum efficacy, fewer acute side effects than phenytoin
- Effective alternative to phenytoin with safer loading profile 9
Treatment of Ictal-Interictal Continuum Patterns
For EEG patterns on the ictal-interictal continuum that do not meet full criteria for seizures, a therapeutic trial of a nonsedating antiseizure medication may be reasonable (Class 2b recommendation) 1:
- The TELSTAR trial showed no clear benefit of aggressive treatment of all rhythmic/periodic patterns 1
- However, patients with unequivocal electrographic seizures (frequencies ≥2.5 Hz) or evolving patterns may benefit from treatment 1
- Use clinical judgment based on pattern characteristics and patient context 1
Refractory Nonconvulsive Status Epilepticus
If seizures persist despite first-line agents 1, 9:
- Escalate to continuous infusions: midazolam, propofol, or pentobarbital
- Consider ketamine as it is probably effective in refractory cases 9
- Maintain continuous EEG monitoring to confirm electrical seizure cessation 1, 9
Critical Pitfalls to Avoid
Do Not Withhold Treatment Based on Clinical Suspicion Alone
- Never assume pseudoseizure without EEG confirmation, as the mortality risk of untreated status epilepticus (5-65%) is too high 7
- Administer benzodiazepines immediately for any convulsive activity lasting >5 minutes, regardless of suspected etiology 7
Do Not Rely on Seizure Prophylaxis
- Seizure prophylaxis in cardiac arrest survivors is NOT recommended (Class 3: No Benefit) 1
- Only treat seizures that are actually detected, not prophylactically 1
Do Not Assume Seizure Cessation Without EEG Confirmation
- Clinical cessation of motor activity does not guarantee electrical seizure termination 7, 3
- Continue EEG monitoring for at least 24 hours after apparent seizure control 1
Do Not Delay EEG for Neurologic Consultation
- While neurologic consultation is reasonable given the specialized nature of EEG interpretation, do not delay ordering the study 2, 3
- Order EEG immediately and consult neurology concurrently 1, 2
Special Considerations
Post-Cardiac Arrest Patients
- Myoclonus occurs in approximately 20% of cardiac arrest survivors and may or may not have an EEG correlate 1
- Subcortical myoclonus without epileptiform activity may not warrant aggressive antiseizure treatment if not interfering with mechanical ventilation 1
- Distinguish between cortical myoclonus (treat) and subcortical myoclonus (may observe) using EEG 1